MedTrace Logo

ICU Sarcopenia Rates by Abdominal CT: Sepsis vs. Trauma

NCT03982628 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 146

Last updated 2020-04-08

No results posted yet for this study

Summary

Using abdominal computed tomography (CT) imaging, the investigators will estimate total body muscle mass at two time points in Intensive Care Unit (ICU) by assessing cross-sectional muscle areas at the L3 vertebral body level. This allows for a determination of the rate of sarcopenia development in the ICU.

With this information, the investigators propose to test if the rates of the development of sarcopenia differ in critically ill subjects with sepsis compared to a reference group of critically ill subjects with trauma (without sepsis).

Conditions

Interventions

DIAGNOSTIC_TEST

Abdominal CT imaging

Routine abdominal CT imaging

Sponsors & Collaborators

  • University of Calgary

    lead OTHER

Principal Investigators

  • Christopher J Grant, MD · University of Calgary

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2020-12-15
Completion
2020-12-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03982628 on ClinicalTrials.gov